Arteriovenous malformations medical therapy: Difference between revisions
No edit summary |
|||
| Line 11: | Line 11: | ||
{{MedCondContrAbs | {{MedCondContrAbs | ||
|MedCond = Intracranial arteriovenous malformation|Abciximab|Alteplase|Tenecteplase|}} | |MedCond = Intracranial arteriovenous malformation|Abciximab|Alteplase|Tenecteplase|Urokinase}} | ||
==References== | ==References== | ||
Revision as of 14:48, 8 September 2014
|
Arteriovenous malformations Microchapters |
|
Differentiating Arteriovenous malformations from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Arteriovenous malformations medical therapy On the Web |
|
American Roentgen Ray Society Images of Arteriovenous malformations medical therapy |
|
Directions to Hospitals Treating Arteriovenous malformations |
|
Risk calculators and risk factors for Arteriovenous malformations medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kalsang Dolma, M.B.B.S.[2]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Treatment for brain AVMs can be symptomatic, and patients should be followed by a neurologist for any seizures, headaches or focal deficits. AVM-specific treatment may also involve endovascular embolization, neurosurgery or radiation therapy. Embolization, that is, cutting off the blood supply to the AVM with coils or particles or glue introduced by a radiographically guided catheter, can be used in addition to either, but is rarely successful in isolation except for in smaller AVMs. The neurological risk of any such intervention is roughly 10%.
Contraindicated medications
Intracranial arteriovenous malformation is considered an absolute contraindication to the use of the following medications: